Most of venture capital in 2024 was a scrum. Dozens of funds crowding the same handful of AI startups, bidding up the same rounds, telling founders the same story. Floating Point walked in the opposite direction - toward flood insurance, private-credit infrastructure, cancer diagnostics, and a digital pharmacy in Brazil. The firm's homepage does not open with a pitch about returns. It opens with two words: embrace complexity.
Those two words are the whole thesis. Floating Point is an early-stage venture firm, founded in 2021, that backs founders rebuilding the operating systems of complex, regulated, and largely un-glamorous industries - healthcare, insurance, logistics, energy, climate and finance. These are the sectors that software-first investors tend to route around, because they are slow, regulated, and hard to understand from the outside. Floating Point treats that difficulty as the point.
The foundersThe operators who priced risk before they wrote checks
The firm was started by John Loser and Edward "Eddie" Segel, two people who had already spent about 15 years working together before they raised a fund. They first met as investors at the hedge fund Bridgewater Associates, where the daily job was understanding complex systems and pricing risk. Then they joined the founding team of Oscar Health, the technology-driven health insurer, where Loser led product, data and risk management. Building a health insurer from scratch is roughly the least glamorous, most regulated startup problem imaginable - which turned out to be excellent training for the fund they would go on to build.
That background is the firm's whole credibility argument. "Operator-investor" is one of the most over-claimed phrases in venture, but Floating Point has a genuine version of it: when its partners sit across from a founder untangling a regulated market, they have lived inside one. They know what it costs, in time and scar tissue, to build in a sector where a compliance filing can matter more than a growth curve. Oscar Health, in particular, was a decade-long lesson in exactly the kind of company Floating Point now funds - technology-heavy, capital-intensive, and pointed at an industry that had barely changed in a generation.
There is also a practical reason the pairing works. A firm that concentrates its bets cannot afford to misjudge a market, and the two partners have spent their careers learning to read complicated systems from the inside - Bridgewater taught them to model risk, Oscar taught them to ship inside a regulated one. When they underwrite a founder in insurance or diagnostics, they are not learning the domain on the founder's time.
The thesisComplexity as a moat, not an obstacle
The counterintuitive idea underneath Floating Point is that the harder a market is to understand, the fewer investors are competing in it - and the more room there is to build something large. The firm frames its work around three ideas it repeats plainly: embrace complexity, act as company builders, and invest for the long term. When Floating Point announced its second fund in April 2024, it described the mission in exactly those terms: a $70M vehicle to invest in complex sectors.
"Company builders" is where the model gets unusual. Rather than spreading a fund across 60 or more names, Floating Point runs a deliberately concentrated portfolio so its partners can spend real time with each founder. In an industry that mostly scaled by writing more checks, choosing to write fewer is a genuine bet - it only works if you are right about the companies you pick, and if you are actually useful to them once you are in.
The third idea - long-term investment - is the quiet contrarian one. Regulated industries change on a scale of years, not quarters. Floating Point positions itself as patient capital, willing to sit with a company through the slow parts rather than rushing to a markup. In healthcare, insurance and climate, where the timelines are stubborn no matter how good the technology is, that patience may be the real edge.
The portfolioA map of the real economy, minus the consumer apps
Read Floating Point's portfolio and a picture of the physical, regulated economy comes into focus. Altana maps global trade and supply chains. Setpoint builds infrastructure for private credit. Floodbase produces "ground truth" flood data that reprices climate risk for insurers. Ataraxis works on AI-driven cancer diagnostics. Firefly runs a virtual-first health plan; Mevo is a digital pharmacy in Brazil; Ledgebrook is a next-generation specialty insurer. Across roughly 40-plus companies, the through-line is consistent - and there is not a single mass-market consumer app in sight. That absence is a thesis, not an accident.
Illustrative view of where Floating Point concentrates. Sectors reflect the firm's stated focus areas; bar lengths are indicative, not a formal allocation.
The networkA bench built before the portfolio
For a firm of its size, Floating Point recruited an unusually deep set of venture partners - operators who help it evaluate and support companies. The bench includes Evan Moore, a co-founder of DoorDash, and Serkan Piantino, a co-founder of Facebook AI Research, alongside senior leaders from companies like Datavant and Oscar Health. It is also backed by institutional limited partners, family offices and strategic investors, among them 53 Stations, the venture arm of The Pritzker Organization. Jason Pritzker serves as an advisor. The pattern is telling: the firm assembled its network before it needed to lean on it.
The market fitWhere a complexity-first fund sits
Floating Point competes for early rounds against generalist seed funds and against thesis-driven, operator-led firms working in hard sectors - the Lux Capitals, Two Sigma Ventures and vertical health, insurtech and climate funds of the world. Its differentiation is not a bigger check or a faster term sheet. It is a filter. "Embrace complexity" quietly rules out most of the deals other investors are fighting over, and points the firm toward markets where domain understanding, not speed, is the deciding factor.
The risk in that strategy is the mirror image of its promise. Concentrated portfolios have less room for error; complex, regulated companies take longer to mature; and patient capital only pays off if the patience is eventually rewarded. Floating Point is young enough - founded in 2021, on its second fund - that the returns story is still being written. What is already clear is the discipline of the approach: a small firm, a narrow filter, and a willingness to underwrite the parts of the economy that keep the lights on but rarely make the headlines.
The modelHow the firm actually works, and who it is for
Mechanically, Floating Point is a conventional venture fund: it raises capital from limited partners, deploys it into early-stage equity, and earns management fees and a share of the eventual gains. What is unconventional is where and how it deploys. The firm writes early checks - roughly pre-seed through Series A - and then commits partner time as a second currency. Because the portfolio is small, a founder who takes Floating Point's money gets more than a wire transfer; they get partners who can help with the specific problems of a regulated business, plus access to a bench of operators who have built at scale.
The customers, in the end, are two audiences. The first is founders in hard sectors - the people building specialty insurers, private-credit rails, climate-risk data, diagnostics and supply-chain intelligence - who want an investor fluent in their world. The second is the limited partners who fund Floating Point's vehicles: institutions, family offices and strategic backers who are buying exposure to the parts of the economy that generalist software funds systematically underweight. The whole design is a wager that serving the first group well produces the returns the second group is after.
For a founder deciding where to raise, the practical value is concrete. You can bring a company that most seed investors would find too technical or too slow, and skip the part where you spend the first meeting teaching your market. You get capital that is comfortable with a longer clock, and a partner who has already carried the weight of a regulated build. In a market where money is abundant but genuine domain understanding is scarce, that combination is the product Floating Point is actually selling.
For founders, the appeal is legible. If you are building in a regulated, technical, slow-to-move industry and you are tired of explaining your market to investors who have never lived in it, Floating Point is a fund that starts from understanding rather than skepticism. For everyone else watching venture chase the same crowded frontier, it is a reminder that some of the largest opportunities are hiding exactly where the crowd isn't looking.